Massive study aims to uncover best treatments for rare tumors

NCT ID NCT05064150

First seen Jan 11, 2026 · Last updated May 07, 2026 · Updated 20 times

Summary

This study follows over 2,500 people with neuroendocrine tumors (NETs) to learn how symptoms and treatments affect their quality of life. Participants fill out surveys about their well-being and care experiences for up to 18 months. The goal is to find which treatments work best with the fewest side effects, helping doctors and patients make better choices.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Allina Health System

    Minneapolis, Minnesota, 55407, United States

  • Mayo Clinic Rochester

    Rochester, Minnesota, 55905, United States

  • Medical College of Wisconsin, Inc

    Milwaukee, Wisconsin, 53226, United States

  • Regents of the University of Michigan

    Ann Arbor, Michigan, 48109-1340, United States

  • The Medical University of South Carolina

    Charleston, South Carolina, 29407-4636, United States

  • The Ohio State University

    Columbus, Ohio, 43210, United States

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599-1350, United States

  • UT Southwestern Medical Center

    Dallas, Texas, 75390-9020, United States

  • University of Florida

    Gainesville, Florida, 32611-5500, United States

  • University of Iowa

    Iowa City, Iowa, 52242, United States

  • University of Kansas Medical Center Research Institute, Inc

    Kansas City, Kansas, 66103-2937, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260-3203, United States

  • University of Utah

    Salt Lake City, Utah, 84112, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203, United States

Conditions

Explore the condition pages connected to this study.